Ensign Peak Advisors, Inc
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 1454984
SALT LAKE CITY, UT
Position in CRNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,507,289
-$232,110 QoQ
Shares Held
67,004
-11.2% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 266 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. CRNX ranks #61 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in CRNX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,507,289 | 67,004 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,739,399 | 75,424 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $12,829,924 | 275,616 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $12,287,083 | 295,008 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $9,075,620 | 315,564 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $17,266,693 | 514,809 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $25,702,539 | 502,690 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $31,520,370 | 616,837 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $27,600,807 | 616,227 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $29,092,742 | 621,507 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $15,501,672 | 435,685 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,440,531 | 384,685 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,870,247 | 270,269 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,340,520 | 270,269 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,945,922 | 270,269 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,813,243 | 92,324 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,578,237 | 84,624 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,338,093 | 60,961 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $971,650 | 34,201 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $444,597 | 21,121 | Shares | Sole | 2021-11-12 | |
| 2020-03-31 | $16,228 | 1,104 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||